Drug intelligence / Profile preview

phosphocreatine

Development stage
Phase 3
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Intravenous, Oral
01

Overview

Phosphocreatine is a naturally occurring, phosphorylated form of creatine that serves as a rapidly mobilizable reserve of high-energy phosphates in skeletal muscle, myocardium, and the brain. It plays a crucial role in cellular energy homeostasis by donating its phosphate group to adenosine diphosphate (ADP), regenerating adenosine triphosphate (ATP), which is essential for muscular contraction and other energy-demanding processes. The enzyme creatine kinase catalyzes this reversible reaction. Phosphocreatine is used intravenously in some countries as a cardioprotective agent during cardiac surgery and for certain cardiovascular conditions. It has also been explored for use in ischemic stroke and other diseases characterized by acute energy deficits, though clinical evidence remains limited. Additionally, it is sometimes used as an athletic supplement to potentially enhance short bursts of muscle strength or power[1][2][8].

Brand names
Neoton
Other names
creatine phosphateN-(N-phosphonoamido)sarcosineN(omega)-phosphonocreatine{[imino(phosphonoamino)methyl](methyl)amino}acetic acidCreatine phosphic acidN-phosphorylcreatinephosphorylcreatineN-(phosphonoamidino)sarcosineNeo-tonN-phosphorocreatineP-creatineCreatine-PCreatine-phosphateCreatinephosphoric acid2-(1-methyl–3-phosphonocarbamimidamido)acetic acid2-[methyl-(N'-phosphonocarbamimidoyl)amino]ethanoic acid[9]

Beyond the preview

Go deeper on phosphocreatine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phosphocreatine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call